Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
New Zealand Clinical Research is seeking a motivated Business Development Manager to drive partnerships with global pharma and biotech companies in New Zealand. This full-time role is based in Auckland or Christchurch and fixes term for 9 months as the team expands in a fast-growing clinical research environment.
You will lead proactive sales conversations, build strong client relationships, and turn opportunities into accurate proposals while coordinating with Finance, Marketing and Operations
Company : New Zealand Clinical Research
Job Type : Full Time
Established in 2020 through the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST), NZCR is at the forefront of early-phase clinical research in New Zealand. With over 35 years of combined research excellence, we have successfully completed 750 trials involving 15,000 participants, showcasing our commitment to advancing medical research. Our physician-led, world-class research units in Auckland, Christchurch, Wellington, and Hamilton conduct complex studies in both healthy participants and patient populations. Partnering with global pharmaceutical and biotech companies, we deliver excellence in clinical research and explore potential new medicines. Recognizing the pivotal role of study participants, NZCR prioritizes their safety and comfort through detailed study information, expert clinical care, and comprehensive support services.
Full-Time, Fixed Term (9 months)
We're looking for a motivated Business Development Manager to join our growing team at NZCR. In this role, you'll be the driving force behind building strong partnerships with global pharmaceutical and biotech companies, securing new opportunities, and helping advance world-class clinical research in New Zealand.
You'll thrive if you enjoy:
This is a fantastic opportunity to make your mark in a fast-growing company where your work directly contributes to global health breakthroughs.